CLARA KOWALSKY: Open Payments
NPI 1194492694 · GLASTONBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,511 in 112 payments from 21 companies in 2025. Trend: 2023 $813 · 2024 $2,542 · 2025 $2,511
Food & beverage: $2,421Education: $90
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $523 |
| UCB, Inc. | 12 | $341 |
| Janssen Biotech, Inc. | 15 | $323 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 13 | $236 |
| Regeneron Healthcare Solutions, Inc. | 3 | $197 |
| Botanix SB Inc | 5 | $143 |
| E.R. Squibb & Sons, L.L.C. | 7 | $140 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 4 | $80 |
| PFIZER INC. | 4 | $72 |
| Galderma Laboratories, L.P. | 3 | $67 |
Products named: RINVOQ, Bimzelx, TREMFYA, DUPIXENT, ILUMYA, SKYRIZI, SOFDRA, Sotyktu.
Industry payments across CT — which companies pay providers there.
